Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma
Aim: To evaluate the performance of MRI-derived radiomic risk score (RRS) and PD-L1
expression to predict overall survival (OS) and progression-free survival (PFS) of patients …
expression to predict overall survival (OS) and progression-free survival (PFS) of patients …
[PDF][PDF] Innovation and advances in precision medicine in head and neck cancer
GA Watson, K Taylor, LL Siu - Critical Issues in Head and Neck …, 2021 - library.oapen.org
The past decade has marked the emergence of precision cancer medicine, a diagnostic and
therapeutic approach that aims to comprehensively characterize the clinical, molecular and …
therapeutic approach that aims to comprehensively characterize the clinical, molecular and …
Baş-boyun skuamöz hücre karsinoması ve makrofaj hücrelerinin apelin/APJ ekseninde moleküler bağlantılarının araştırılması
F Seçer Çelik - 2022 - acikerisim.erbakan.edu.tr
Özet Kanser, kardiyovasküler hastalıklardan sonra dünyada en çok ölüm oranlarına sahip
hastalıktır. Günümüzde kanser tedavisi kemoterapi, radyoterapi ve cerrahi müdahalelerle …
hastalıktır. Günümüzde kanser tedavisi kemoterapi, radyoterapi ve cerrahi müdahalelerle …